Tissue factor antisense oligonucleotides prevent renal ischemia-reperfusion injury

Transplantation

Volumn 76, Issue 5, 2003, Pages 786-791

  Matsuyama, Masahide ^a,b   Yoshimura, Rikio ^b   Akioka, Kiyokazu ^a   Okamoto, Masahiko ^a   Ushigome, Hidetaka ^a   Kadotani, Yayoi ^a   Nakatani, Tatsuya ^b   Yoshimura, Norio ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MONOCLONAL ANTIBODY; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; THROMBOPLASTIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; KIDNEY DISTAL TUBULE; KIDNEY ISCHEMIA; KIDNEY VEIN; MACROPHAGE; MALE; MONOCYTE; NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RENAL ARTERY; REPERFUSION INJURY; SURVIVAL RATE;

5' UNTRANSLATED REGIONS; ANIMALS; BLOOD UREA NITROGEN; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY TRANSPLANTATION; KIDNEY TUBULAR NECROSIS, ACUTE; MALE; MICROCIRCULATION; MONOCYTES; OLIGONUCLEOTIDES, ANTISENSE; POTASSIUM; RATS; RATS, INBRED LEW; REPERFUSION INJURY; RNA, MESSENGER; SURVIVAL RATE; THROMBOPLASTIN;

EID: 0141702167     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000079630.68668.C2     Document Type: Article

References (23)

1. Nemerson Y. Tissue factor and hemostasis. Blood 1988; 71: 1.
2. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissue. Am J Pathol 1989; 134: 1087.
3. Oliiver V, Houssaye S, Ternisien C, et al. Endotoxin-induced tissue factor messenger RNA in human monocytes is negatively regulated by cyclic AMP-dependent mechanism. Blood 1993; 81: 973.
4. Brisseau GF, Dackiw APB, Cheung PYC, et al. Posttranscriptional regulation of macrophage tissue factor expression by antioxidants. Blood 1995; 85: 1025.
5. Ushigome H, Sano H, Okamoto M, et al. The role of tissue factor in renal ischemic reperfusion injury of the rat. J Surg Res 2002; 102: 102.
6. Warr TA, Rao LVM, Rapaport SI. Disseminated intravascular coagulation in rabbits induced by administration ofendotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement o plasma extrinsic pathway inhibitor activity. Blood 1990; 75: 1481.
7. Bennet CF, Codon T, Grimm T, et al. Inhibition of endothelial cell-leukocyte adhesion molecule expression with antisense oligonucleotides. J Immunol 1994; 152: 3530.
8. Andrade M, Scozzari A, Cole DL, et al. Efficient synthesis of antisense oligonucleotide phosphorothiates. Bioorg Med Chem Lett 1994; 4: 2017.
9. Stein C, Krieg AM. Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides. Antisense Res Dev 1994; 4: 67.
10. Nakamura K, Kadotani Y, Ushigome H, et al. Antisense oligonucleotide for tissue factor inhibits hepatic ischemic reperfusion injury. Biochem Biophys Res Commun 2002; 297: 433.
11. Bennett CF, Chiang MY, Chan H, et al. Cationic enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharmacol 1992; 41: 1023.
12. Kobayashi Y, Yoshimura N, Nakamura K, et al. Expression of tissue factor in hepatic ischemic-reperfusion injury of the rat. Transplantation 1998; 66: 708.
13. Imamura T, Iyama K, Takeya M, et al. Role of macrophage tissue factor in development of delayed hypersensitivity reaction in monkey skin. Cell Immunol 1993; 152: 614.
14. Archipoff G, Beretz A, Freyssinet JM, et al. Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumor necrosis factor, thrombin or phorbol ester. Biochem J 1991; 273: 679.
15. Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986; 163: 740.
16. Crooke ST, Lebleu B, Antisense oligonucleotides in the context of modern molecular drug discovery and development. In: Crooke ST, Lebleu B, eds. Antisense research and applications. Boca Raton, FL: CRC Press 1993, p 7.
17. Crooke ST. Therapeutic applications of oligonucleotides. Annu Rev Pharmacol Toxicol 1992; 32: 329.
18. Akhtar S, Kole R, Juliano RL. Stability of antisense DNA oligonucleotides in cellular extracts and sera. Life Sci 1991; 49: 1793.
19. Milligan CF, Matteucci MD, Martin JC. Current concepts in antisense drug design. J Med Chem 1993; 36: 1923.
20. Hoke GD, Draper K, Freier SM, et al. Effect of phosphothioate capping on antisense oligonucleotides stability, hybridization and anti-viral efficacy versus herpes simplex virus infection. Nucleic Acids Res 1991; 19: 5743.
21. Schmid E, Muller TH, Budzinski RM, et al. Signaling by E-selectin and ICAM-1 induces endothelial tissue factor production via autocrine secretion of platelet-activating factor and tumor necrosis factor alpha. J Interferon Cytokine Res 1995; 15: 819.
22. Dragun D, Tullius SG, Park JK, et al. ICAM-1 antisense oligodeoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation. Kidney Int 1998; 54: 590.
23. Toda K, Kayano K, Karimova A, et al. Antisense intercellular adhesion molecule-1 (ICAM-1) oligodeoxyribonucleotide delivered during organ preservation inhibits posttransplant ICAM-1 expression and reduces primary lung isograft failure. Circ Res 2000; 86: 166.